INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 38 filers reported holding INSMED INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,317,751 | +3.8% | 1,330,000 | 0.0% | 0.00% | +100.0% |
| Q2 2023 | $1,269,618 | +3.9% | 1,330,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,221,525 | -1.7% | 1,330,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,243,000 | -24.0% | 1,330,000 | -23.1% | 0.00% | -50.0% |
| Q2 2022 | $1,635,000 | -5.5% | 1,730,000 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $1,730,000 | -2.9% | 1,730,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,782,000 | -0.5% | 1,730,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $1,791,000 | -1.3% | 1,730,000 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $1,814,000 | – | 1,730,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
| Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
| LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
| DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
| Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
| Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
| Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |